Corvex (NASDAQ:MOVE) versus Globant (NYSE:GLOB) Head-To-Head Survey

Globant (NYSE:GLOB) and Corvex (NASDAQ:MOVE) are both small-cap technology companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations.

Profitability

This table compares Globant and Corvex’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Globant	4.63%	9.28%	6.18%
Corvex	-624.33%	N/A	-9.12%

Institutional and Insider Ownership

91.6% of Globant shares are held by institutional investors. Comparatively, 16.6% of Corvex shares are held by institutional investors. 2.7% of Globant shares are held by insiders. Comparatively, 23.7% of Corvex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Globant and Corvex”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globant	$2.45 billion	0.72	$102.92 million	$2.55	15.88
Corvex	$430,000.00	806.36	-$18.28 million	($18.86)	-0.58

Globant has higher revenue and earnings than Corvex. Corvex is trading at a lower price-to-earnings ratio than Globant, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Globant has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Corvex has a beta of 0.9, meaning that its share price is 10% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for Globant and Corvex, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globant	2	11	5	0	2.17
Corvex	1	0	0	0	1.00

Globant currently has a consensus target price of $46.38, indicating a potential upside of 14.51%. Given Globant’s stronger consensus rating and higher possible upside, analysts clearly believe Globant is more favorable than Corvex.

Summary

Globant beats Corvex on 12 of the 14 factors compared between the two stocks.

About Globant

Globant S.A., together with its subsidiaries, provides technology services worldwide. It provides digital solutions comprising blockchain, cloud technologies, cybersecurity, data and artificial intelligence, digital experience and performance, code, Internet of Things, metaverse, and engineering and testing; and enterprise technology solutions and services, such as Agile organization, Cultural Hacking, process optimization services, as well as AWS, Google Cloud, Microsoft, Oracle, SalesForce, SAP, and ServiceNow technology solutions. Further, the company provides e-commerce, conversational interfaces, design, digital marketing, and digital product delivery services. Additionally, it operates Augoor, an AI-powered platform; MagnifAI, an AI-powered solution for software quality assurance; StarMeUp, a science-based AI platform; WaaSabi, a finance platform; Walmeric, a lead-to-revenue management platform; GeneXus, a suit of AI development tools; Navigate for process optimization powerhouse; BeHealthy, a white-label platform; and FluentLab, an AI conversational and engagement solution. The company offers its services to various industries, including media and entertainment, professional services, technology and telecommunications, travel and hospitality, banks, financial services and insurance, consumer, retail and manufacturing, health care, and others. The company was formerly known as IT Outsourcing S.L. and changed its name to Globant S.A. in December 2012. Globant S.A. was founded in 2003 and is based in Luxembourg, Luxembourg.

About Corvex

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.